SCHEMBL3162285

SCHEMBL3162285

CC(=O)NCCNc1cc(N2CCN(C(=O)Cc3cccc([N+](=O)[O-])c3)CC2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.44
SIGMAR1 Q99720 1/20 0.42
LMNA P02545 7/20 0.41
ENPP2 Q13822 3/20 0.41
ALDH1A1 P00352 7/20 0.40
HTT P42858 4/20 0.40
MET P08581 1/20 0.39
MAPT P10636 5/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
MAPK1 P28482 3/20 0.39
POLB P06746 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTR1A P08908 1/20 0.38
HTR1D P28221 1/20 0.38
HTR1B P28222 1/20 0.38
KCNH2 Q12809 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3155589 0.93 SIGMAR1 (0.47) HRH4SIGMAR1LMNAALDH1A1HTT
SCHEMBL3163575 0.92 POLB (0.44) HRH4LMNAENPP2ALDH1A1HTT
SCHEMBL3163437 0.89 LMNA (0.54) HRH4LMNAALDH1A1HTTMAPT
SCHEMBL3166539 0.88 POLB (0.43) HRH4LMNAALDH1A1HTTSMN1; SMN2
SCHEMBL3164879 0.88 GBA1 (0.48) HRH4LMNAALDH1A1SMN1; SMN2MEN1
SCHEMBL3165234 0.88 MEN1 (0.47) SIGMAR1MAPTPOLBMEN1KMT2A
SCHEMBL3177354 0.85 KMT2A (0.49) SIGMAR1LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL3164902 0.85 GFER (0.47) HRH4LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL3166615 0.84 MGLL (0.45) LMNAALDH1A1HTTMAPTSMN1; SMN2
SCHEMBL3164771 0.84 SMN1; SMN2 (0.44) HRH4LMNAMAPTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed